Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $41.45 USD
Change Today -0.46 / -1.10%
Volume 398.0K
FMS On Other Exchanges
Symbol
Exchange
OTC US
Xetra
New York
Mexico
Frankfurt
As of 4:15 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

fresenius medical care-adr (FMS) Snapshot

Open
$41.59
Previous Close
$41.91
Day High
$41.88
Day Low
$41.45
52 Week High
03/16/15 - $42.85
52 Week Low
05/20/14 - $31.28
Market Cap
25.8B
Average Volume 10 Days
138.0K
EPS TTM
--
Shares Outstanding
622.9M
EX-Date
05/13/14
P/E TM
--
Dividend
$0.53
Dividend Yield
1.27%
Current Stock Chart for FRESENIUS MEDICAL CARE-ADR (FMS)

Related News

No related news articles were found.

fresenius medical care-adr (FMS) Related Businessweek News

No Related Businessweek News Found

fresenius medical care-adr (FMS) Details

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care services related to the dialysis treatment a patient receives with end stage renal disease (ESRD); and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of 3,361 outpatient dialysis clinics in approximately 45 countries worldwide; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also provides pharmacy services, such as delivery and supply of renal medications to patients at homes or to dialysis clinics directly; vascular, cardiovascular, and endovascular specialty services; and offers products for the treatment of ESRD. In addition, it offers laboratory services that include blood, urine, and other bodily fluid testing services; and hemodialysis (HD) machines, modular components for dialysis machines, polysulfone dialyzers, bloodlines, HD solutions and concentrates, needles, connectors, machines for water treatment, data administration systems, dialysis chairs, phosphate binders, iron products, and other renal drug products. Further, the company provides peritoneal dialysis systems and solutions for continuous ambulatory peritoneal dialysis and automated peritoneal dialysis; and adsorbers, which are filters used in other extracorporeal therapies; and distributes specific instruments for vascular access, as well as other supplies, such as bandages, clamps, and injections. The company sells its products to clinics, hospitals, and specialized treatment clinics through local sales forces, independent distributors, dealers, and sales agents. The company was founded in 1996 and is headquartered in Bad Homburg, Germany.

99,895 Employees
Last Reported Date: 02/25/15
Founded in 1996

fresenius medical care-adr (FMS) Top Compensated Officers

Chairman of the Management Board for Freseniu...
Total Annual Compensation: $2.2M
Chief Financial Officer of Fresenius Medical ...
Total Annual Compensation: $1.3M
Chief Executive Officer of Fresenius Medical ...
Total Annual Compensation: $1.5M
Chief Executive Officer of Asia Pacific Divis...
Total Annual Compensation: $1.2M
Chief Executive Officer of Global Manufacturi...
Total Annual Compensation: $931.0K
Compensation as of Fiscal Year 2014.

fresenius medical care-adr (FMS) Key Developments

Fresenius Medical Care AG & Co. KGAA to Report Fiscal Year 2014 Final Results on Mar 31, 2015

Fresenius Medical Care AG & Co. KGAA announced that they will report fiscal year 2014 final results on Mar 31, 2015

Fresenius Is Reportedly In Talks To Buy Nephromor

Nephromor Ltd. is slated for sale to Fresenius Medical Care AG & Co. KGAA (DB:FME) for ILS 350 million, sources inform "Globes."

Fresenius Medical Care AG & Co. KGAA to Approve Dividend for 2014

At the annual general meeting to be held on May 19, 2015, shareholders will be asked to approve a dividend of 0.78 per share, an increase of 1% from 2013 of 0.77.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FMS:US $41.45 USD -0.46

FMS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $68.50 USD -0.26
Becton Dickinson and Co $143.59 USD -2.05
DaVita HealthCare Partners Inc $81.28 USD -0.89
Mylan NV $59.35 USD -0.65
Toray Industries Inc ¥1,007 JPY -5.50
View Industry Companies
 

Industry Analysis

FMS

Industry Average

Valuation FMS Industry Range
Price/Earnings 24.4x
Price/Sales 1.6x
Price/Book 2.7x
Price/Cash Flow 25.1x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FRESENIUS MEDICAL CARE-ADR, please visit www.fmc-ag.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.